| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/29/2009 | CN100519546C Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
| 07/29/2009 | CN100519528C Compounds with analgesic effect |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518827C Controlled release hydrocodone formulations |
| 07/29/2009 | CN100518742C Triterpene compounds which are effective on improvement of brain function |
| 07/29/2009 | CN100518741C Pregnane steroids for use in the treatment of cns dysfunction |
| 07/29/2009 | CN100518739C A retroviral immunotherapy |
| 07/29/2009 | CN100518735C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/29/2009 | CN100518726C Pharmaceutical solutions of modafinil compounds |
| 07/29/2009 | CN100518725C Venlafaxine hydrochloride liquid slow-release preparation and its preparation method |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566778 Central nervous system disorders; psychological disorders |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566730 Substituted aminoethers for the treatment of Alzheimer's disease |
| 07/28/2009 | US7566728 Advance circadian rhythm disorders; using opioid receptor antagonist |
| 07/28/2009 | US7566727 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one/5,6-dihydro-furo[2,3-c] pyrrol-4-one derivative ligands for alpha 7 nicotinic acetylcholine receptor |
| 07/28/2009 | US7566720 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
| 07/28/2009 | US7566709 4-(3-(2-Fluorophenyl)-1-phenyl-1H-pyrazol-4-ylmethyl)morpholine; 5HT2A/5HT2C receptors; central nervous system; schizophrenia; antidepressants; dementia; Parkinson's disease; Azheimer's disease; Huntington's disease; Tourette's syndrome; anxiolytic agents; congnition activators; analgesics |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566449 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins |
| 07/28/2009 | US7566446 Wound healing and treatment of fibrosis |
| 07/28/2009 | CA2542292C Triterpene compounds which are effective on improvement of brain function |
| 07/28/2009 | CA2462453C Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 07/28/2009 | CA2447329C 1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/28/2009 | CA2370147C Piperidine-indole compounds having 5-ht6 affinity |
| 07/28/2009 | CA2315235C Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same |
| 07/23/2009 | WO2009092073A2 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| 07/23/2009 | WO2009092071A2 Amino acid and peptide pro-drugs of phenolic analgesics and uses thereof |
| 07/23/2009 | WO2009091964A2 Method for treating addiction using quercetin-containing compositions |
| 07/23/2009 | WO2009091932A2 Treatment of mild dementia of the alzheimer's disease type |
| 07/23/2009 | WO2009091898A2 6-and 7-amino isoquinoline compounds and methods for making and using the same |
| 07/23/2009 | WO2009091831A1 Compound forms and uses thereof |
| 07/23/2009 | WO2009091813A1 Compounds useful as alpha7 nicotinic acetylcholine receptor agonists |
| 07/23/2009 | WO2009091759A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | WO2009091735A1 Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/23/2009 | WO2009091605A2 Taste titration therapies |
| 07/23/2009 | WO2009091542A2 Antibodies to bufadienolides prevent inhbition of na/katpase and prolong survival in shock |
| 07/23/2009 | WO2009091341A1 Novel peptides and protein and uses thereof |
| 07/23/2009 | WO2009091059A1 Composition for diagnosis, treatment or prevention of epilepsy |
| 07/23/2009 | WO2009091016A1 Condensed aminodihydrothiazine derivative |
| 07/23/2009 | WO2009090933A1 Virus growing in hypoxic cell or virus vector expressing gene therein |
| 07/23/2009 | WO2009090623A1 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological applications thereof |
| 07/23/2009 | WO2009090556A2 Artificial reproduction of pharmaceutical conditions of dependency to tobacco and other addictive drugs (opiacea, psychostimulants, alcohol) by combination of nicotine and a ligand (agonist or 5 antagonist) of 5-ht1a receptors |
| 07/23/2009 | WO2009090431A1 Cyclic triazo and diazo sodium channel blockers |
| 07/23/2009 | WO2009090227A2 PEPTIDES HAVING BINDING AFFINITY TO AN ANTIBODY WHICH RECOGNIZES AN EPITOPE ON AN α1 LOOP 2 OR β2 LOOP 1 OF AN ADRENORECEPTOR |
| 07/23/2009 | WO2009090202A1 Monomaleate monohydrate salt of a 5ht1a receptor antagonist |
| 07/23/2009 | WO2009090177A1 Bifeprunox derivatives |
| 07/23/2009 | WO2009090173A1 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/23/2009 | WO2009089680A1 Method of modulating membrane potential of a cell |
| 07/23/2009 | WO2009089678A1 Scirr10 neurotrophic factor, its receptor and uses thereof |
| 07/23/2009 | WO2009089635A1 Treating neurodegenerative diseases with progranulin (pgrn) |
| 07/23/2009 | WO2009071725A3 Use of valproate for the treatment of fear and phobia in subjects with alzheimer's disease |
| 07/23/2009 | WO2009071690A3 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 07/23/2009 | WO2009071689A3 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 07/23/2009 | WO2009064422A9 Hepatocyte growth factor pathway activators in fibrotic connective tissue diseases |
| 07/23/2009 | WO2009053742A3 Salts of nefopam and their use in therapy |
| 07/23/2009 | WO2009053549A8 Rimonabant dmso solvate, method for preparing same and pharmaceutical compositions containing same |
| 07/23/2009 | WO2009046845A3 Use of a lactoferrin partial peptide peptide as a therapeutic agent |
| 07/23/2009 | WO2009043523A3 Cortistatin 17 and neuropeptide 1 for use as therapeutic agent |
| 07/23/2009 | WO2009040084A3 Use of a peptide as a therapeutic agent |
| 07/23/2009 | WO2009040034A3 Use of a peptide as a therapeutic agent |
| 07/23/2009 | WO2009039973A3 Use of peptide arg-asn-ile-ala-glu-ile-ile-lys-asp-ile-oh or its combination with the peptide asp-arg-gly-asp-ser-oh as a therapeutic agent |
| 07/23/2009 | WO2009033816A3 Use of the combination of thymosin beta 10 and thymosin alpha 1 peptides as a therapeutic agent |
| 07/23/2009 | WO2009033773A3 Use endothelin 2, alone or combined with a nonapeptide, a peptide as a therapeutic agent |
| 07/23/2009 | WO2009033761A3 Use of a fragment of hcv nucleo protein, alone or together with endothelin-3, as a therapeutic agent |
| 07/23/2009 | WO2009016520A3 Thiophosphi(o)nic acid derivatives and their use as agonists or antagonists for metabotropic glutamate receptors |
| 07/23/2009 | WO2008142693A8 Regulation of myelination by nectin-like (necl) molecules |
| 07/23/2009 | WO2008103351A3 Heterocyclic aspartyl protease inhibitors |
| 07/23/2009 | WO2008084504A3 Pharmaceutical compositions of angiotensin ii receptor blockers |
| 07/23/2009 | WO2008061796A3 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 07/23/2009 | WO2008001369A8 Use of cb2 receptor agonists for promoting neurogenesis |
| 07/23/2009 | WO2007145589A8 Peptides that are capable of binding to amyloid-beta peptide. |
| 07/23/2009 | WO2007094027A8 Methods for the diagnosis of proliferative and/or conformational diseases |
| 07/23/2009 | US20090186945 Abuse-resistant amphetamine prodrugs |
| 07/23/2009 | US20090186940 Synthesis of Scabronines and Analogues Thereof |
| 07/23/2009 | US20090186937 Method for Treating Addiction Using Quercetin-Containing Compositions |
| 07/23/2009 | US20090186936 Tea beverages containing proanthocyanidins |
| 07/23/2009 | US20090186921 Azacyclic compounds |
| 07/23/2009 | US20090186919 Piperidine derivatives for treatment of alzheimer's disease |
| 07/23/2009 | US20090186916 Aminoindane derivative or salt thereof |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186908 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/23/2009 | US20090186904 Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof |
| 07/23/2009 | US20090186903 Aripiprazole complex formulation and method |
| 07/23/2009 | US20090186902 Substituted Tetrahydroimidazopyridine Compounds and the Use Thereof in the Treatment of Pain and Other Conditions |
| 07/23/2009 | US20090186899 Substituted Sulfonamide Compounds |
| 07/23/2009 | US20090186895 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 07/23/2009 | US20090186888 Novel fused pyrrolocarbazoles |
| 07/23/2009 | US20090186882 Cgrp receptor antagonists |
| 07/23/2009 | US20090186879 Tricyclic compounds and use thereof |
| 07/23/2009 | US20090186872 Loxapine analogs and methods of use thereof |
| 07/23/2009 | US20090186846 Methods to reprogram splice site selection in pre-messenger RNAs |
| 07/23/2009 | US20090186802 Cell Penetrating Peptide Conjugates for Delivering of Nucleic Acids into a Cell |
| 07/23/2009 | US20090186378 recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide; for immunosuppression or to stimulate nerve growth and regeneration |
| 07/23/2009 | US20090186099 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186010 Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseases |
| 07/23/2009 | US20090186005 Methods and Compositions For Treating Motor Neuron Diseases Comprising Mesenchymal Stem Cells |